Clinical trial
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe
NCT04397237
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedPrevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
COVID-19verified · MONDO: COVID-19
Sjogren's Syndromecandidate · MONDO: Sjogren syndrome
Axial Spondyloarthritisunresolved
Interventions
Sponsors & collaborators
Pitié-Salpêtrière Hospitallead sponsor
Università degli Studi di Ferraracollaborator
Rheumazentrum Ruhrgebietcollaborator
University College, Londoncollaborator
University of Coimbracollaborator
Universidad Complutense de Madridcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04397237 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.